International Biotechnology Trust’s Dermira, Inc. DERM Stock Holding History

International Biotechnology Trust’s Portfolio DERM Stock Details DERM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-30,000	Closed	-$454K	–	71
2019 Q4	$454K	Hold	30,000	–	–	0.16%	58
2019 Q3	$191K	Hold	30,000	–	–	0.09%	58
2019 Q2	$287K	Hold	30,000	–	–	0.11%	64
2019 Q1	$407K	Buy	+30,000	New	+$250K	0.15%	61
2018 Q1	–	Sell	-108,000	Closed	-$3M	–	71
2017 Q4	$3M	Hold	108,000	–	–	1.06%	30
2017 Q3	$2.92M	Sell	108,000 -21,000	-16%	-$550K	1.14%	28
2017 Q2	$3.76M	Buy	129,000 +24,000	+23%	+$730K	1.43%	23
2017 Q1	$3.58M	Buy	105,000 +60,000	+133%	+$1.94M	1.37%	22
2016 Q4	$1.36M	Buy	+45,000	New	+$1.45M	0.61%	33

International Biotechnology Trust's DERM Position: Q1 2020 in Review

International Biotechnology Trust sold out of Dermira, Inc. (DERM) in Q1 2020, closing a stake of 30,000 shares — an estimated $454K sold.

International Biotechnology Trust first reported a position in DERM in Q4 2016 and held it in 9 quarters. The position peaked at $3.76M in Q2 2017. 0 funds tracked by Wall St. Rank hold DERM as of Q1 2020.

International Biotechnology Trust reported no remaining Dermira, Inc. position as of Q1 2020 after selling out during the quarter.
International Biotechnology Trust sold 30,000 Dermira, Inc. shares in Q1 2020, an estimated $454K.
International Biotechnology Trust first reported a position in Dermira, Inc. in Q4 2016 and held it in 9 quarters.
International Biotechnology Trust's Dermira, Inc. position peaked at $3.76M in Q2 2017.
0 funds tracked by Wall St. Rank held Dermira, Inc. as of Q1 2020.

Based on International Biotechnology Trust's 13F filing for Q1 2020, filed 18 May 2020.